China Life stock: iFAST raises target to HKD 39.10 for China Life stock

Published on 10/20/2026 at 16:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sixteen analysts set a HKD 30.51 average target on October 20. China Life stock costs EUR 2.62 on October 20, 2026; HKEX shares fell 2.54 percent.

Analyst target and reporting date

iFAST raised its China Life target to HKD 39.10 on September 17, 2026.
Sixteen analysts set an average target of HKD 30.51 on October 20, 2026.
China Life stock costs EUR 2.62 at Lang & Schwarz on October 20, 2026 at 4:07 p.m. CEST; HKEX shares fell 2.54 percent from HKD 23.62.
China Life's market capitalization stood at HKD 1.1 trillion on October 20, 2026.

China Life, CNE1000002L3, Illustration mit AI erstellt.

China Life Insurance Company Limited (ISIN CNE1000002L3) has a fresh analyst target of HKD 39.10, while the broader analyst average stood at HKD 30.51 on October 20, 2026. FSM Global reported on September 17, 2026 that iFAST had raised its target to HKD 39.10. At Lang & Schwarz, the stock was trading at EUR 2.62 on October 20, 2026 at 4:07 p.m. CEST; China Life's Hong Kong shares fell 2.54 percent to HKD 23.02 from HKD 23.62.

Target distance remains wide

The HKD 39.10 target is 69.85 percent above the HKD 23.02 Hong Kong share price. That calculation uses the same home-market currency and places the target well above the average analyst view of HKD 30.51.

The valuation case rests partly on first-half performance. For the six months ended June 30, 2026, revenue reached CNY 434.60 billion, up 81.50 percent from the prior-year period, while net profit rose 228.60 percent to CNY 134.50 billion. FSM Global also reported that investment yield increased from 3.29 percent to 5.58 percent in the same period.

HKEX range and valuation

China Life's HKEX price was HKD 23.02 on October 20, 2026, against a 52-week range of HKD 22.90 to HKD 36.16. The price stood 0.52 percent above the yearly low and 36.34 percent below the yearly high. Its price-to-earnings ratio was 3.89, and market capitalization was HKD 1.1 trillion.

Results date is October 29

MarketScreener lists October 29, 2026 as the next China Life earnings release. The company operates life, health and accident insurance businesses in China, and its financial profile remains closely linked to investment returns as well as premium growth.

Comparison with peers

China Life: down 2.54 percent, P/E 3.89, market capitalization HKD 1.1 trillion

New China Life Insurance (HKEX, HKD): down 5.99 percent, P/E 3.62, market capitalization HKD 158.8 billion

Ping An Insurance (HKEX, HKD): down 1.70 percent, P/E 5.80, market capitalization HKD 890.9 billion

Price stays near the yearly low

The Hong Kong price was 0.52 percent above its 52-week low on October 20, 2026. The euro quotation at Lang & Schwarz stood at EUR 2.62 on October 20, 2026 at 4:07 p.m. CEST, while the Hong Kong listing was down 2.54 percent from HKD 23.62.

The further course of trading is shown by the continuously updated real-time quote of China Life stock.